Skip to content

Effect of endurance training with blood flow restriction during inpatient rehabilitation in patients with total hip arthroplasty

Effect of endurance training with blood flow restriction during inpatient rehabilitation in patients with total hip arthroplasty - BFR-AE-THA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033669
Enrollment
26
Registered
2024-04-24
Start date
2024-03-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip joint replacement/total hip arthroplasty

Interventions

Group 1: Intervention group (IG): As part of the inpatient rehabilitation, the IG performs endurance training (4-5x per week, 20 min per training session) with BFR at 40% of the individual arterial oc

Sponsors

Otto-von-Guericke-Universität Magdeburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Hip joint replacement

Exclusion criteria

Exclusion criteria: peripheral arterial occlusive disease from stage II according to Fontaine, venous insufficiency (varicose veins) and thrombosis of the lower extremities and pelvic veins, lymphoedema, acute or chronic infections of the extremities, pregnancy and breastfeeding and inability to rehabilitate

Design outcomes

Primary

MeasureTime frame
Hip function (HOOS) Measurements: Pre + Post (3 weeks)

Secondary

MeasureTime frame
Pain (200 mm VAS) Muscle thickness of rectus femoris (sonography) Body composition (BIA) Range of motion hip abduction and flexion (goniometer) Postural control in single-leg stance (force plate) Muscle power of the lower extremities (FRTST) Endurance capacity (6MWT) Measurement: Pre + Post (3 weeks) Effort and exercise-induced muscle pain perception (Borg 6-20) Measurement: during each training session

Countries

Germany

Contacts

Public ContactLutz Schega

Otto-von-Guericke-Universität Magdeburg

lutz.schega@ovgu.de+49 391 67 56126

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026